Trial Outcomes & Findings for Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery (NCT NCT02356471)
NCT ID: NCT02356471
Last Updated: 2018-09-27
Results Overview
Feasibility will be defined as the number of patients who self-report wearing the CAM device at least 16 days of the 21 day period.
COMPLETED
NA
34 participants
21 days
2018-09-27
Participant Flow
Participant milestones
| Measure |
Supportive Care (Consumer-based Activity Monitor)
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Overall Study
STARTED
|
34
|
|
Overall Study
COMPLETED
|
28
|
|
Overall Study
NOT COMPLETED
|
6
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery
Baseline characteristics by cohort
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=34 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
2 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
32 Participants
n=5 Participants
|
|
Age, Continuous
|
70.99 years
STANDARD_DEVIATION 5.28 • n=5 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
22 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
34 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
29 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
34 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 21 daysPopulation: 34 patients enrolled in study. 28 patients had data collected. Due to challenges associated with data collection, partial data was collected for 18 patients.
Feasibility will be defined as the number of patients who self-report wearing the CAM device at least 16 days of the 21 day period.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=28 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Number of Patients Who Self-report Wearing the Consumer-based Activity Monitor at Least 16 Days of the 21 Day Period
|
9 Participants
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: 16 subjects had sufficient data for partial analysis.
This outcome measure will be the change in daily steps for participants before and after major oncologic surgery. Change in median (IQR) steps reported.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=16 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Daily Steps for Participants Before and After Major Oncologic Surgery
|
-2573 steps
Interval -2685.0 to -2461.0
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 9 subjects had SPPB measured at baseline and 90 days.
This outcome measure is to compare pre- and post-operative mobility using the Short Physical Performance Battery (SPPB). Median (IQR) change in SPPB from baseline to 90 days is reported.The scale range is 0-16. Higher scores denotes better outcomes.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=9 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Short Physical Performance Battery (SPPB)
|
0 units on a scale
Interval -1.0 to 2.0
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 10 subjects had 400m walk measured at baseline and 90 days
This outcome measure is to compare pre- and post-operative mobility testing using the 400-meter walk. Median (IQR) change in 400 m walk from baseline to 90 days is reported. The duration it takes the participant to walk 400 meters will be recorded in seconds.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=10 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Duration of 400-meter Walk
|
-69.5 seconds
Interval -166.1 to 30.6
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Data were not collected and therefore analysis cannot performed.
This outcome measure is to compare pre- and post-operative self-reported mobility using the Pepper Assessment Tool for Disability (PAT-D). Median (IQR) change in PAT-D is reported.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 7 subjects had MAT-sf measured at baseline and 90 days.
This outcome measure is to compare pre- and post-operative self-reported mobility using the Mobility Assessment Tool-Short Form (MAT-sf). Median (IQR) change in MAT-sf is reported. The score range is 30-80 and higher scores denotes better outcomes.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=7 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in the Mobility Assessment Tool-Short Form (MAT-sf).
|
4.52 units on a scale
Interval -0.465 to 5.42
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: 5 subjects have CHAMPs data at baseline and 90 days.
This outcome measure is to compare self-reported activity data (CHAMPS) during the pre- and post-operative period. Median (IQR) change in CHAMPS is reported. CHAMPS measures activity of the participant and how long they could do the activity. The score range is 0-108. Higher scores denotes better outcomes.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=5 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in CHAMPS Between the Pre- and Post-operative Period
|
-1 score on a scale
Interval -1.0 to 2.0
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 6 subjects reported FACT-G at baseline and 90 days.
FACT-G is a 27-item compilation of general questions divided into 4 primary quality of life (QOL) domains: physical well-being, social/family well-being, emotional well-being, and functional well-being. The subscales are summed to produce a total score. The total score range is 0-108 and a higher score indicates better quality of life. Outcomes is to compare FACT-G at baseline and 90 days. Change in FACT-G is reported in median (IQR).
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=6 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Health-related Quality of Life (FACT-G) Questionnaire
|
-1 units on a scale
Interval -1.0 to 2.0
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 6 subjects had pain VAS measured at baseline and 90 days.
The pain VAS is a unidimensional measure of pain intensity providing a range of scores from 0-100. A higher score indicates greater pain intensity. Change in median (IQR) pain score from baseline to 90 days is reported.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=6 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Pain Assessment -Pain Visual Analog Scale, (PVAS)
|
21 units on a scale
Interval 3.0 to 34.5
|
SECONDARY outcome
Timeframe: baseline and 90 daysPopulation: Only 6 subjects reported fatigue VAS at baseline and 90 days.
The fatigue VAS is a unidimensional measure of fatigue providing a range of scores from 0-100. A higher score indicates greater fatigue. Change in median (IQR) fatigue score from baseline to 90 days is reported.
Outcome measures
| Measure |
Supportive Care (Consumer-based Activity Monitor)
n=6 Participants
Patients wear Fitbit Zip (portable pedometer device) to track physical activity for 7 days before undergoing surgery and for 21 more days after undergoing surgery.
Management of Therapy Complications Fitbit Zip (portable pedometer device): Use pedometer to monitor physical activity
Questionnaire Administration: Ancillary studies
Quality-of-Life Assessment: Ancillary studies
|
|---|---|
|
Change in Fatigue Assessment- Fatigue Visual Analog Scale (FVAS).
|
6 units on a scale
Interval 0.0 to 25.5
|
Adverse Events
Supportive Care (Consumer-based Activity Monitor)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Clancy Clark
Wake Forest University Health Sciences
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place